Back to Woodline Partners LP Woodline Partners LP

ABUSABUS
Showing 8 of 18 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in ARBUTUS BIOPHARMA CORP

Woodline Partners LP holds 2.3M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $11M as of 2026-Q2. The position was increased (+13.5% shares). ABUS represents 0.0% of Woodline Partners LP's portfolio.

Current Value

$11M

Current Shares

2.3M

Total Value Change

+$8.4M

Total Shares Change

+1.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+13.5%
$11M0.0%$4.80
31
2026-Q1
Decreased
2M
-8.1%
$9M0.0%$4.50
0
2025-Q4
Increased
2.2M
+1.0%
$10.5M0.0%$4.81
28
2025-Q3
Decreased
2.2M
-13.3%
$9.8M0.0%$4.54
0
2025-Q2
Decreased
2.5M
-5.9%
$7.7M0.0%$3.09
0
2025-Q1
Increased
2.7M
+173.3%
$9.3M0.1%$3.49
45
2024-Q4
Increased
971,628
+45.4%
$3.2M0.0%$3.27
36
2024-Q3
Decreased
668,153
-27.9%
$2.6M0.0%$3.85
0

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used